Cargando…
Transmembrane protein 170B is a novel breast tumorigenesis suppressor gene that inhibits the Wnt/β-catenin pathway
The identification of specific drug targets guides the development of precise cancer treatments. Compared with oncogenes, tumor suppressor genes have been poorly studied in the treatment of breast cancer. We integrate the microRNA expression array from GEO (Gene Expression Omnibus) and TCGA (The Can...
Autores principales: | Li, Mengwei, Han, Yanzhen, Zhou, Haoze, Li, Xin, Lin, Chenyu, Zhang, Erhao, Chi, Xiaowei, Hu, Jialiang, Xu, Hanmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833782/ https://www.ncbi.nlm.nih.gov/pubmed/29367600 http://dx.doi.org/10.1038/s41419-017-0128-y |
Ejemplares similares
-
Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas
por: Li, Mengwei, et al.
Publicado: (2020) -
PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis
por: Tang, Yuling, et al.
Publicado: (2022) -
Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
por: Zhang, Erhao, et al.
Publicado: (2018) -
Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12
por: Chi, Xiaowei, et al.
Publicado: (2019) -
Farnesoid X receptor antagonizes Wnt/β-catenin signaling in colorectal tumorigenesis
por: Yu, Junhui, et al.
Publicado: (2020)